Timothy C. Rodell, M.D., FCCP

Interim Chief Executive Officer and Director

Timothy C. Rodell, M.D., FCCP, joined Aethlon in December, 2018 as Interim Chief Executive Officer.  Previously Dr. Rodell  was President, Chief Executive Officer and a member of the board of directors of GlobeImmune, Inc. from 2002 until 2016 prior to a majority acquisition of the company.   He remains a member of the GlobeImmune board of directors. 

During his over 30 year career in the biopharma industry, Dr. Rodell has built a wealth of experience in global product development, operations and financing including raising over $300 million in domestic and foreign private and public financings.  At GlobeImmune, Dr. Rodell led the company through the advancement of five products from the bench into human clinical trials and closed multiple financings, including an IPO and the establishment of two major corporate alliances.  Prior to GlobeImmune, Dr. Rodell was President and Chief Executive Officer at RxKinetix, Inc. and has held senior management positions at OXIS International, Inc. and Cortech, Inc.

Before moving to industry Dr. Rodell practiced and taught as a faculty member at the University Of Colorado School Of Medicine.  Dr. Rodell holds an M.D. from the University of North Carolina at Chapel Hill, is board certified in Internal Medicine and Pulmonary Medicine and is a Fellow of the American College of Chest Physicians.

James B. Frakes

Chief Financial Officer and Senior Vice President – Finance

Mr. Frakes joined Aethlon Medical in January 2008. He has 27 years of CFO level financial responsibility for publicly traded companies, as well as, specific knowledge and experience in equity (IPO, follow-on public offerings and private placements) and debt transactions, acquisitions, public reporting and Sarbanes-Oxley section 404 internal control requirements.

Mr. Frakes received an MBA from the University of Southern California, and completed his BA with Honors at Stanford University.

Michael Jacobs

Senior Scientist

Michael has an extensive and diverse background in medical device product development and process improvement. His previous research has led to multiple publications in various peer-reviewed journals from Elsevier and the Royal Society of Chemistry. Michael holds a Bachelor’s degree in Biology and a Master’s degree in Biomedical Engineering from the University of Texas at Dallas.

Annette Marleau, PhD

Director of Research

An expert in immunology, virology, and cell biology who formerly held academic research positions at the The Scripps Research Institute (La Jolla, CA) and the University of Nebraska Medical Center (Omaha, NE). Dr. Marleau holds a Bachelor’s degree in Biomedical Sciences from the University of Waterloo, a Master’s degree in Reproductive Immunology from the Ontario Veterinary College at the University of Guelph, and a PhD in Immunology from the University of Western Ontario in Canada.

Lisa M. Boswell

Director, Quality Systems and Regulatory Affairs

Ms. Boswell has over 15 years of experience in Quality Control, Quality Assurance and Regulatory Affairs in both the biopharmaceutical and medical device industries, most recently as Director, Quality Assurance and Regulatory Affairs at ZOLL Data Systems, Inc. Prior to ZOLL, Ms. Boswell spent 10 years in positions of increasing responsibility in Quality Control at GlobeImmune, Inc.  Ms. Boswell holds undergraduate degrees in Chemistry and Biology from St. Andrews Presbyterian College and an M.S. in Engineering Management from Tufts University.